Simplex Trading, LLC Voyager Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$156 Billion
Q1 2025

A detailed history of Simplex Trading, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,693 shares of VYGR stock, worth $7,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,693

Previous 10,074 73.27%

Holding current value

$7,890

Previous $57,000 84.21%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$3.38 - $6.04 $24,947 - $44,581	-7,381 Reduced 73.27%	2,693 $9,000
Q4 2024 Feb 11, 2025	BUY	$5.27 - $8.07 $37,785 - $57,861	7,170 Added 246.9%	10,074 $57,000
Q3 2024 Nov 08, 2024	SELL	$5.77 - $9.27 $6,162 - $9,900	-1,068 Reduced 26.89%	2,904 $16,000
Q2 2024 Jul 25, 2024	SELL	$7.42 - $10.54 $56,681 - $80,515	-7,639 Reduced 65.79%	3,972 $31,000
Q1 2024 Apr 25, 2024	BUY	$7.15 - $10.84 $83,018 - $125,863	11,611 New	11,611 $108,000
Q3 2023 Nov 01, 2023	BUY	$7.55 - $11.25 $57,168 - $85,185	7,572 New	7,572 $58,000
Q1 2023 Apr 27, 2023	BUY	$6.0 - $10.78 $99,738 - $179,195	16,623 New	16,623 $128,000
Q3 2021 Oct 28, 2021	BUY	$2.63 - $4.12 $1,904 - $2,982	724 New	724 $2,000
Q2 2021 Aug 12, 2021	SELL	$3.94 - $5.44 $10,409 - $14,372	-2,642 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$4.61 - $9.04 $12,179 - $23,883	2,642 New	2,642 $12,000
Q4 2020 Feb 02, 2021	SELL	$7.15 - $12.28 $10,474 - $17,990	-1,465 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$10.01 - $13.75 $3,553 - $4,881	355 Added 31.98%	1,465 $15,000
Q2 2020 Jul 13, 2020	SELL	$8.05 - $14.21 $7,929 - $13,996	-985 Reduced 47.02%	1,110 $14,000
Q1 2020 Apr 29, 2020	SELL	$6.8 - $14.66 $57,820 - $124,653	-8,503 Reduced 80.23%	2,095 $19,000
Q4 2019 Feb 05, 2020	BUY	$12.82 - $16.85 $52,549 - $69,068	4,099 Added 63.07%	10,598 $147,000
Q3 2019 Oct 15, 2019	SELL	$16.31 - $28.29 $283,761 - $492,189	-17,398 Reduced 72.8%	6,499 $111,000
Q2 2019 Jul 26, 2019	BUY	$19.18 - $27.88 $151,157 - $219,722	7,881 Added 49.21%	23,897 $650,000
Q1 2019 Apr 18, 2019	BUY	$8.0 - $19.66 $127,344 - $312,947	15,918 Added 16242.86%	16,016 $0
Q4 2018 Jan 16, 2019	SELL	$8.59 - $18.05 $2,482 - $5,216	-289 Reduced 74.68%	98 $0
Q3 2018 Oct 23, 2018	BUY	$17.11 - $21.74 $1,950 - $2,478	114 Added 41.76%	387 $7,000
Q2 2018 Jul 30, 2018	SELL	$16.76 - $23.92 $1,676 - $2,392	-100 Reduced 26.81%	273 $5,000
Q1 2018 Apr 26, 2018	SELL	$16.16 - $31.31 $196,230 - $380,197	-12,143 Reduced 97.02%	373 $7,000
Q4 2017 Jan 10, 2018	BUY	$12.26 - $25.88 $148,468 - $313,406	12,110 Added 2982.76%	12,516 $207,000
Q3 2017 Oct 25, 2017	BUY	$8.37 - $20.59 $3,398 - $8,359	406	406 $8,000

Others Institutions Holding VYGR

# of Institutions

121

Shares Held

34.6M

Call Options Held

12.9K

Put Options Held

37.7K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $113M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Voyager Therapeutics, Inc. Transaction History